The tentative contents is:

Demystifying Forecasting: Myths versus Reality; Performing a Strategic Value Assessments; What Is Forecast Value Added; Practical Applications and Methods in Forecasting; Tool Box Approach to Forecasting; Demand-Driven Consensus Forecasting; Performance Metrics; Cultural barriers in Forecasting.

Praise for Demand-Driven Forecasting

A Structured Approach to Forecasting

"There are authors of advanced forecasting books who take an academic approach to explaining forecast modeling that focuses on the construction of arcane algorithms and mathematical proof that are not very useful for forecasting practitioners. Then, there are other authors who take a general approach to explaining demand planning, but gloss over technical content required of modern forecasters. Neither of these approaches is well-suited for helping business forecasters critically identify the best demand data sources, effectively apply appropriate statistical forecasting methods, and properly design efficient demand planning processes. In Demand-Driven Forecasting, Chase fills this void in the literature and provides the reader with concise explanations for advanced statistical methods and credible business advice for improving ways to predict demand for products and services. Whether you are an experienced professional forecasting manager, or a novice forecast analyst, you will find this book a valuable resource for your professional development." --Daniel Kiely, Senior Manager, Epidemiology, Forecasting & Analytics, Celgene Corporation

"Charlie Chase has given forecasters a clear, responsible approach for ending the timeless tug of war between the need for 'forecast rigor' and the call for greater inclusion of 'client judgment.' By advancing the use of 'domain knowledge' and hypothesis testing to enrich base-case forecasts, he has empowered professional forecasters to step up and impact their companies' business results favorably and profoundly, all the while enhancing the organizational stature of forecasters broadly." --Bob Woodard, Vice President, Global Consumer and Customer Insights, Campbell Soup Company

Key Topics Covered:

Foreword. Preface. Acknowledgments. Chapter 1: Demystifying Forecasting: Myths versus Reality. Chapter 2: What Is Demand-Driven Forecasting? Chapter 3: Overview of Forecasting Methods. Chapter 4: Measuring Forecast Performance. Chapter 5: Quantitative Forecasting methods using time series data Chapter 6: Quantitative Forecasting Methods Using Causal Data. Chapter 7: Weighted Combined Forecasting Methods. Chapter 8: Sensing, Shaping, and Linking Demand to Supply: A Case Study Using MTCA. Chapter 9: Strategic Value Assessment: Assessing the Readiness of Your Demand Forecasting Process. Index.

For more information visit http://www.researchandmarkets.com/research/a97ba1/demanddriven_fore

SOURCE: Research and Markets

Research and Markets 
Laura Wood, Senior Manager, 
press@researchandmarkets.com 
U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716

Today's PriceWatch Alerts cover the following stocks: Visa, Inc. (NYSE: V), Schlumberger Limited (NYSE: SLB), Celgene Corporation (Nasdaq: CELG), Illumina Inc. (Nasdaq: ILMN), and American Water Works Company, Inc. (NYSE: AWK).

In today's unsure markets these brief PriceWatch Alerts contain concise detailed strategies for each covered stock and include position protection tactics designed to potentially defend investors from unexpected market shifts. While other market reports only provide stock news and opinion, we offer strategies that position investments against uncertainty and increase chances of making a profit, even if a stock goes down.

"Our PriceWatch Alerts go beyond other market reports. Along with a brief concise overview, each PriceWatch Alert provides useful strategies, which ensure potential investments are protected with basic hedging techniques," says Reid Stratton, Seven Summits Senior Analyst. "These brief company reports contain information that can benefit expert and novice investors who want to stay ahead of the market."

For essential information on stocks poised to move go to:

http://www.iotogo.com/s/111809B for Seven Summits Strategic Investments' PriceWatch Alerts.

Seven Summits Investment Research is an independent investment research group, which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. For more information go to www.SevenSummitsInvestmentResearch.com . CRD# 137114

All stocks and options shown are examples only-- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes--expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available from Catherine at 800-698-9101 or at http://www.cboe.com/Resources/Intro.aspx . Privacy policy available upon request.

SOURCE Seven Summits Investment Research

http://www.sevensummitsstrategicinvestments.com

For more information and for complete abstracts, please visit http://ash.confex.com/ash/2009/webprogram/start.html

About Celgene

Celgene Corporation, based in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the Company's website at www.celgene.com.

This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the Company's control. The Company's actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. The factors that could cause actual results, performance, or achievements to differ from the forward-looking statements are discussed in the Company's filings with the Securities and Exchange Commission, such as the Company's Form 10-K, 10-Q and 8-K reports. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.

SOURCE: Celgene Corporation

Celgene Corporation 
David W. Gryska, 908-673-9059 
Senior Vice President and Chief Financial Officer 
or 
Brian P. Gill, 908-673-9530 
Vice President, Corporate Communications